nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—ankylosing spondylitis	0.953	1	CpDpCtD
Methylergometrine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00931	0.248	CbGbCtD
Methylergometrine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00706	0.188	CbGbCtD
Methylergometrine—CYP3A4—Betamethasone—ankylosing spondylitis	0.00605	0.161	CbGbCtD
Methylergometrine—CYP3A4—Prednisolone—ankylosing spondylitis	0.00597	0.159	CbGbCtD
Methylergometrine—CYP3A4—Prednisone—ankylosing spondylitis	0.00564	0.15	CbGbCtD
Methylergometrine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00352	0.0938	CbGbCtD
Methylergometrine—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.000195	0.0209	CcSEcCtD
Methylergometrine—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.000179	0.0192	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.000178	0.0192	CcSEcCtD
Methylergometrine—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.000162	0.0174	CcSEcCtD
Methylergometrine—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.000162	0.0174	CcSEcCtD
Methylergometrine—Sweating increased—Prednisolone—ankylosing spondylitis	0.000142	0.0152	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.000141	0.0152	CcSEcCtD
Methylergometrine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00013	0.014	CcSEcCtD
Methylergometrine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00013	0.014	CcSEcCtD
Methylergometrine—Bradycardia—Prednisolone—ankylosing spondylitis	0.000119	0.0127	CcSEcCtD
Methylergometrine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000118	0.0127	CcSEcCtD
Methylergometrine—Sweating increased—Betamethasone—ankylosing spondylitis	0.000118	0.0127	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.000118	0.0127	CcSEcCtD
Methylergometrine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000109	0.0117	CcSEcCtD
Methylergometrine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000109	0.0117	CcSEcCtD
Methylergometrine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000106	0.0114	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.000104	0.0112	CcSEcCtD
Methylergometrine—Sweating increased—Prednisone—ankylosing spondylitis	0.000103	0.0111	CcSEcCtD
Methylergometrine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	9.92e-05	0.0106	CcSEcCtD
Methylergometrine—Bradycardia—Dexamethasone—ankylosing spondylitis	9.9e-05	0.0106	CcSEcCtD
Methylergometrine—Bradycardia—Betamethasone—ankylosing spondylitis	9.9e-05	0.0106	CcSEcCtD
Methylergometrine—Hallucination—Dexamethasone—ankylosing spondylitis	9.67e-05	0.0104	CcSEcCtD
Methylergometrine—Hallucination—Betamethasone—ankylosing spondylitis	9.67e-05	0.0104	CcSEcCtD
Methylergometrine—Convulsion—Prednisolone—ankylosing spondylitis	8.79e-05	0.00943	CcSEcCtD
Methylergometrine—Hypertension—Prednisolone—ankylosing spondylitis	8.76e-05	0.0094	CcSEcCtD
Methylergometrine—Bradycardia—Prednisone—ankylosing spondylitis	8.62e-05	0.00925	CcSEcCtD
Methylergometrine—Hallucination—Prednisone—ankylosing spondylitis	8.42e-05	0.00904	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	8.28e-05	0.00888	CcSEcCtD
Methylergometrine—Convulsion—Triamcinolone—ankylosing spondylitis	8.08e-05	0.00867	CcSEcCtD
Methylergometrine—Tachycardia—Prednisolone—ankylosing spondylitis	8.08e-05	0.00867	CcSEcCtD
Methylergometrine—Convulsion—Methylprednisolone—ankylosing spondylitis	8.06e-05	0.00865	CcSEcCtD
Methylergometrine—Hypertension—Triamcinolone—ankylosing spondylitis	8.05e-05	0.00864	CcSEcCtD
Methylergometrine—Hypertension—Methylprednisolone—ankylosing spondylitis	8.03e-05	0.00862	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	8e-05	0.00859	CcSEcCtD
Methylergometrine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	7.61e-05	0.00817	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	7.59e-05	0.00815	CcSEcCtD
Methylergometrine—Haematuria—Methotrexate—ankylosing spondylitis	7.51e-05	0.00806	CcSEcCtD
Methylergometrine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	7.45e-05	0.00799	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisolone—ankylosing spondylitis	7.43e-05	0.00797	CcSEcCtD
Methylergometrine—Tachycardia—Triamcinolone—ankylosing spondylitis	7.43e-05	0.00797	CcSEcCtD
Methylergometrine—Tachycardia—Methylprednisolone—ankylosing spondylitis	7.41e-05	0.00795	CcSEcCtD
Methylergometrine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.36e-05	0.0079	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.34e-05	0.00788	CcSEcCtD
Methylergometrine—Convulsion—Dexamethasone—ankylosing spondylitis	7.33e-05	0.00787	CcSEcCtD
Methylergometrine—Convulsion—Betamethasone—ankylosing spondylitis	7.33e-05	0.00787	CcSEcCtD
Methylergometrine—Hypertension—Betamethasone—ankylosing spondylitis	7.31e-05	0.00784	CcSEcCtD
Methylergometrine—Hypertension—Dexamethasone—ankylosing spondylitis	7.31e-05	0.00784	CcSEcCtD
Methylergometrine—Hypotension—Methylprednisolone—ankylosing spondylitis	7.1e-05	0.00761	CcSEcCtD
Methylergometrine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	6.91e-05	0.00741	CcSEcCtD
Methylergometrine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	6.91e-05	0.00741	CcSEcCtD
Methylergometrine—Paraesthesia—Triamcinolone—ankylosing spondylitis	6.83e-05	0.00733	CcSEcCtD
Methylergometrine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	6.82e-05	0.00732	CcSEcCtD
Methylergometrine—Dyspnoea—Triamcinolone—ankylosing spondylitis	6.79e-05	0.00728	CcSEcCtD
Methylergometrine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	6.77e-05	0.00727	CcSEcCtD
Methylergometrine—Nervous system disorder—Betamethasone—ankylosing spondylitis	6.77e-05	0.00727	CcSEcCtD
Methylergometrine—Tachycardia—Dexamethasone—ankylosing spondylitis	6.74e-05	0.00723	CcSEcCtD
Methylergometrine—Tachycardia—Betamethasone—ankylosing spondylitis	6.74e-05	0.00723	CcSEcCtD
Methylergometrine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	6.68e-05	0.00716	CcSEcCtD
Methylergometrine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	6.68e-05	0.00716	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—ankylosing spondylitis	6.6e-05	0.00708	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—ankylosing spondylitis	6.57e-05	0.00705	CcSEcCtD
Methylergometrine—Hypotension—Betamethasone—ankylosing spondylitis	6.45e-05	0.00692	CcSEcCtD
Methylergometrine—Hypotension—Dexamethasone—ankylosing spondylitis	6.45e-05	0.00692	CcSEcCtD
Methylergometrine—Convulsion—Prednisone—ankylosing spondylitis	6.38e-05	0.00685	CcSEcCtD
Methylergometrine—Hypertension—Prednisone—ankylosing spondylitis	6.36e-05	0.00683	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.21e-05	0.00666	CcSEcCtD
Methylergometrine—Paraesthesia—Betamethasone—ankylosing spondylitis	6.2e-05	0.00665	CcSEcCtD
Methylergometrine—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.2e-05	0.00665	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisone—ankylosing spondylitis	6.01e-05	0.00645	CcSEcCtD
Methylergometrine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	6e-05	0.00644	CcSEcCtD
Methylergometrine—Nervous system disorder—Prednisone—ankylosing spondylitis	5.9e-05	0.00633	CcSEcCtD
Methylergometrine—Tachycardia—Prednisone—ankylosing spondylitis	5.87e-05	0.0063	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisone—ankylosing spondylitis	5.81e-05	0.00624	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.65e-05	0.00606	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.65e-05	0.00606	CcSEcCtD
Methylergometrine—Dizziness—Prednisolone—ankylosing spondylitis	5.47e-05	0.00587	CcSEcCtD
Methylergometrine—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.46e-05	0.00586	CcSEcCtD
Methylergometrine—Abdominal pain—Betamethasone—ankylosing spondylitis	5.46e-05	0.00586	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisone—ankylosing spondylitis	5.4e-05	0.0058	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—ankylosing spondylitis	5.34e-05	0.00573	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—ankylosing spondylitis	5.24e-05	0.00563	CcSEcCtD
Methylergometrine—Rash—Prednisolone—ankylosing spondylitis	5.22e-05	0.0056	CcSEcCtD
Methylergometrine—Dermatitis—Prednisolone—ankylosing spondylitis	5.21e-05	0.00559	CcSEcCtD
Methylergometrine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.2e-05	0.00558	CcSEcCtD
Methylergometrine—Headache—Prednisolone—ankylosing spondylitis	5.18e-05	0.00556	CcSEcCtD
Methylergometrine—Dizziness—Triamcinolone—ankylosing spondylitis	5.03e-05	0.0054	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	5.03e-05	0.00539	CcSEcCtD
Methylergometrine—Dizziness—Methylprednisolone—ankylosing spondylitis	5.02e-05	0.00539	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—ankylosing spondylitis	4.93e-05	0.00529	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.92e-05	0.00528	CcSEcCtD
Methylergometrine—Nausea—Prednisolone—ankylosing spondylitis	4.92e-05	0.00528	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	4.86e-05	0.00521	CcSEcCtD
Methylergometrine—Vomiting—Triamcinolone—ankylosing spondylitis	4.84e-05	0.00519	CcSEcCtD
Methylergometrine—Vomiting—Methylprednisolone—ankylosing spondylitis	4.83e-05	0.00518	CcSEcCtD
Methylergometrine—Rash—Triamcinolone—ankylosing spondylitis	4.8e-05	0.00515	CcSEcCtD
Methylergometrine—Dermatitis—Triamcinolone—ankylosing spondylitis	4.79e-05	0.00514	CcSEcCtD
Methylergometrine—Rash—Methylprednisolone—ankylosing spondylitis	4.79e-05	0.00514	CcSEcCtD
Methylergometrine—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.78e-05	0.00513	CcSEcCtD
Methylergometrine—Headache—Triamcinolone—ankylosing spondylitis	4.77e-05	0.00512	CcSEcCtD
Methylergometrine—Headache—Methylprednisolone—ankylosing spondylitis	4.76e-05	0.00511	CcSEcCtD
Methylergometrine—Abdominal pain—Prednisone—ankylosing spondylitis	4.75e-05	0.0051	CcSEcCtD
Methylergometrine—Diarrhoea—Betamethasone—ankylosing spondylitis	4.73e-05	0.00507	CcSEcCtD
Methylergometrine—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.73e-05	0.00507	CcSEcCtD
Methylergometrine—Hypotension—Methotrexate—ankylosing spondylitis	4.7e-05	0.00504	CcSEcCtD
Methylergometrine—Dizziness—Dexamethasone—ankylosing spondylitis	4.57e-05	0.0049	CcSEcCtD
Methylergometrine—Dizziness—Betamethasone—ankylosing spondylitis	4.57e-05	0.0049	CcSEcCtD
Methylergometrine—Nausea—Triamcinolone—ankylosing spondylitis	4.52e-05	0.00485	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—ankylosing spondylitis	4.51e-05	0.00484	CcSEcCtD
Methylergometrine—Nausea—Methylprednisolone—ankylosing spondylitis	4.51e-05	0.00484	CcSEcCtD
Methylergometrine—Dyspnoea—Methotrexate—ankylosing spondylitis	4.48e-05	0.00481	CcSEcCtD
Methylergometrine—Vomiting—Dexamethasone—ankylosing spondylitis	4.39e-05	0.00471	CcSEcCtD
Methylergometrine—Vomiting—Betamethasone—ankylosing spondylitis	4.39e-05	0.00471	CcSEcCtD
Methylergometrine—Rash—Dexamethasone—ankylosing spondylitis	4.35e-05	0.00467	CcSEcCtD
Methylergometrine—Rash—Betamethasone—ankylosing spondylitis	4.35e-05	0.00467	CcSEcCtD
Methylergometrine—Dermatitis—Dexamethasone—ankylosing spondylitis	4.35e-05	0.00467	CcSEcCtD
Methylergometrine—Dermatitis—Betamethasone—ankylosing spondylitis	4.35e-05	0.00467	CcSEcCtD
Methylergometrine—Headache—Dexamethasone—ankylosing spondylitis	4.33e-05	0.00464	CcSEcCtD
Methylergometrine—Headache—Betamethasone—ankylosing spondylitis	4.33e-05	0.00464	CcSEcCtD
Methylergometrine—Diarrhoea—Prednisone—ankylosing spondylitis	4.12e-05	0.00442	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.11e-05	0.00441	CcSEcCtD
Methylergometrine—Nausea—Dexamethasone—ankylosing spondylitis	4.1e-05	0.0044	CcSEcCtD
Methylergometrine—Nausea—Betamethasone—ankylosing spondylitis	4.1e-05	0.0044	CcSEcCtD
Methylergometrine—Dizziness—Prednisone—ankylosing spondylitis	3.98e-05	0.00427	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—ankylosing spondylitis	3.97e-05	0.00426	CcSEcCtD
Methylergometrine—Vomiting—Prednisone—ankylosing spondylitis	3.82e-05	0.0041	CcSEcCtD
Methylergometrine—Rash—Prednisone—ankylosing spondylitis	3.79e-05	0.00407	CcSEcCtD
Methylergometrine—Dermatitis—Prednisone—ankylosing spondylitis	3.79e-05	0.00407	CcSEcCtD
Methylergometrine—Headache—Prednisone—ankylosing spondylitis	3.77e-05	0.00404	CcSEcCtD
Methylergometrine—Nausea—Prednisone—ankylosing spondylitis	3.57e-05	0.00383	CcSEcCtD
Methylergometrine—Diarrhoea—Methotrexate—ankylosing spondylitis	3.44e-05	0.00369	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—ankylosing spondylitis	3.32e-05	0.00357	CcSEcCtD
Methylergometrine—Vomiting—Methotrexate—ankylosing spondylitis	3.2e-05	0.00343	CcSEcCtD
Methylergometrine—Rash—Methotrexate—ankylosing spondylitis	3.17e-05	0.0034	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—ankylosing spondylitis	3.17e-05	0.0034	CcSEcCtD
Methylergometrine—Headache—Methotrexate—ankylosing spondylitis	3.15e-05	0.00338	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—ankylosing spondylitis	2.99e-05	0.0032	CcSEcCtD
